SAN DIEGO, June 30, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired NovoCure Limited NVCR securities between January 5, 2023 and June 5, 2023. NovoCure Limited is an oncology company that…Read More
NovoCure Limited NVCR Equity Alert Robbins LLP Urges NVCR Investors with Significant Losses to Contact the Law Firm Regarding the NovoCure Limited Class Action NovoCure NASDAQNVCR
